Baraclude



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis B 73.9%
Hepatic Cirrhosis 6.3%
Hypertension 3.4%
Chronic Hepatitis B 3.2%
Hepatitis B Virus Test 2.3%
Hepatitis B Virus 1.5%
Ascites 1.5%
Hiv Infection 1.2%
Diabetes Mellitus 0.8%
Gastritis 0.7%
Chronic Hepatitis 0.7%
Rash 0.6%
Asthma 0.5%
Hepatitis C 0.5%
Hyperammonaemia 0.5%
Lymphoma 0.5%
Varices Oesophageal 0.5%
Antiretroviral Therapy 0.4%
Coronary Artery Disease 0.4%
Gastric Ulcer 0.4%
Hepatic Neoplasm Malignant 15.4%
Death 14.8%
Pregnancy 14.0%
Renal Failure 7.6%
Drug Ineffective 4.0%
Lactic Acidosis 3.9%
Drug Resistance 3.6%
Myalgia 3.4%
White Blood Cell Count Decreased 3.4%
Blood Creatine Phosphokinase Increased 3.3%
Rash 3.0%
Renal Impairment 3.0%
Hepatic Failure 2.8%
Hepatitis B Dna Increased 2.8%
Viral Load Increased 2.8%
Hepatic Cirrhosis 2.6%
Hepatocellular Carcinoma 2.5%
Vomiting 2.5%
Alopecia 2.3%
Thrombocytopenia 2.3%
Secondary
Adult T-cell Lymphoma/leukaemia 20.6%
Hepatitis B 17.4%
Hiv Infection 10.0%
Product Used For Unknown Indication 6.9%
Hepatic Cirrhosis 5.8%
Antiretroviral Therapy 4.5%
Prophylaxis 4.1%
Constipation 3.9%
Antifungal Prophylaxis 3.7%
Depression 2.8%
Hypertension 2.8%
Pain 2.4%
Pneumonia 2.4%
Gastritis 2.0%
Gastrooesophageal Reflux Disease 2.0%
Hyperlipidaemia 1.9%
Rheumatoid Arthritis 1.9%
Metastases To Bone 1.7%
Proctitis 1.7%
Stomatitis 1.7%
Suicide Attempt 9.7%
Drug Exposure During Pregnancy 6.9%
Interstitial Lung Disease 6.9%
Stevens-johnson Syndrome 6.9%
Hepatic Neoplasm Malignant 5.6%
Iron Deficiency Anaemia 5.6%
Liver Disorder 5.6%
Thrombocytopenia 5.6%
Acute Myocardial Infarction 4.2%
Agranulocytosis 4.2%
Exposure During Pregnancy 4.2%
Hepatitis B Dna Increased 4.2%
Polyneuropathy 4.2%
Pregnancy 4.2%
Pyrexia 4.2%
Stridor 4.2%
Tachycardia 4.2%
Ventricular Tachycardia 4.2%
Abortion Induced 2.8%
Abortion Spontaneous 2.8%
Concomitant
Product Used For Unknown Indication 17.2%
Hepatic Neoplasm Malignant 13.7%
Hepatitis B 13.2%
Prophylaxis 12.0%
Hypertension 7.0%
Abdominal Pain 4.2%
Gastric Ulcer 4.0%
Hepatic Cirrhosis 3.3%
Palmar-plantar Erythrodysaesthesia Syndrome 3.1%
Diarrhoea 2.9%
Infection Prophylaxis 2.7%
Rheumatoid Arthritis 2.6%
Decreased Appetite 2.1%
Constipation 2.0%
Cancer Pain 1.8%
Liver Disorder 1.8%
Nausea 1.8%
Chronic Hepatitis B 1.6%
Multiple Myeloma 1.5%
Bronchitis 1.5%
Palmar-plantar Erythrodysaesthesia Syndrome 9.8%
Pyrexia 9.2%
White Blood Cell Count Decreased 8.2%
Hepatic Function Abnormal 7.1%
Hepatic Neoplasm Malignant 5.4%
Rash 5.4%
Left Ventricular Dysfunction 4.9%
Nausea 4.9%
Renal Failure 4.3%
Sepsis 4.3%
Thrombocytopenia 4.3%
Vomiting 4.3%
Liver Disorder 3.8%
Stomatitis 3.8%
Urticaria 3.8%
Diarrhoea 3.3%
Hepatic Failure 3.3%
Interstitial Lung Disease 3.3%
Pancreatitis Acute 3.3%
Platelet Count Decreased 3.3%